Medical Technologies

“The SingHealth-A*STAR HTP synergises SingHealth’s strengths in clinical care and healthcare innovation and A*STAR’s expertise in science and technology to catalyse the development of new solutions through research and innovation, and empower healthcare researchers and innovators to better leverage emerging technologies that will bring about better care outcomes for our patients and the population.”

Professor Ivy Ng

Group CEO, Singhealth

“A*STAR has been a key supporter of Respiree from the times when the core technology was conceived in the Laboratory of Bio-optical Imaging at SBIC. This includes the development of and provision of funding for technology development, the licensing of the resultant technology and ultimately the spin-off of Respiree. In addition to assist in financing the development of Respiree, the members of A*ccelerate have played a critical role in supporting fund raising through introduction of suitable investors, regulatory advice and mentorship in the development and commercialisation of Respiree.”

Dr Gurpreet Singh

CEO, Respiree

“MiRXES i4.0 IVD manufacturing facility aims to contribute towards Singapore’s Manufacturing 2030 vision together with esteemed partners like A*STAR. Working together, there is great potential for Singapore to become a critical node in the global diagnostics value chain, and I am proud that MiRXES will be part of this legacy, which also has synergy with our goal to be the global leader for IVD manufacturing.”

Dr Lihan Zhou

CEO, MiRXES

"Singapore is at the forefront of medical innovation and R&D- and we value the opportunity to work with Singaporean organisations like A*STAR to develop the next generation of healthcare technology. Leveraging both our strengths has not only resulted in new innovations to GE’s solutions- they are helping to address the fast-growing healthcare needs of Southeast Asia and the world.”

Michael Barber

President and CEO, Molecular Imaging and Computed Tomography, GE Healthcare